Skip to content

Effect of ACEI / ARB on Contrast-Induced acute kidney injury: A prospective, multicenter, randomized, parallel-controlled trial

Effect of ACEI / ARB on Contrast-Induced acute kidney injury: A prospective, multicenter, randomized, parallel-controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015188
Enrollment
Unknown
Registered
2018-03-13
Start date
2018-03-15
Completion date
Unknown
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast-Induced acute kidney injury

Interventions

1:stop using ACEI/ARB before use of contrast agent
2:don't stop using ACEI/ARB before use of contrast agent

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) all patients who are currently using ACEI/ARB with cardiac catheterization or enhanced CT examination; (2) 18 years of age or older; (3) the signing of the informed consent.

Exclusion criteria

Exclusion criteria: (1) patients with end-stage renal failure who need dialysis treatment or after heart and kidney transplantation; (2) the history of contrast media exposure within 48 hours before or 72 hours after examination; (3) allergy to radionuclide; (4) severe infection; (5) surgical operation was performed within 2 days after CT examination; (6) the combination of multiple myeloma, urinary tract obstruction, aortic dissection and other diseases that can cause acute renal injury; (7) check within 2 weeks before using aminoglycoside nephrotoxic drugs etc.; (8) the researchers believe that it is not suitable for the study.

Design outcomes

Primary

MeasureTime frame
creatinine;

Countries

China

Contacts

Public ContactLiu Huadong

Shenzhen People's Hospital

zyyhlb@yeah.net+86 13724397998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026